Profil bibliographique

Rebecca Wurm‐Kuczera

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

19Publications signalées

115Citations signalées

6Affiliations récentes

Institutions déclarées

Humboldt-Universität zu Berlin Universitätsklinikum Erlangen Pharis Biotec (Germany)Franklin University Freie Universität Berlin Charité - Universitätsmedizin Berlin

Domaines associés

Lymphoma Diagnosis and TreatmentCAR-T cell therapy researchCutaneous lymphoproliferative disorders researchChronic Lymphocytic Leukemia ResearchMonoclonal and Polyclonal Antibodies Research

Publications récentes

2025 conference-abstractOpenAlex

Correlates of response to combined checkpoint and BTK inhibition for treatment of richter transformation: Extended follow-up from the prospective RT1 trial

Othman Al‐Sawaf, Sandra Robrecht, Adam Giza, Anantharamanan Rajamani et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

The role of RhoA in diffuse large B-cell lymphoma

Dominique Jahn, Rebecca Wurm‐Kuczera, Tim Beringer, Sebastian Wolf et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Efficacy and safety of vipor (P) in relapsed or refractory large B-cell lymphoma

Thomas Oellerich, Rebecca Wurm‐Kuczera, Shashwat Sahay, Meng Wang et autres

1 citationBlood

Accès ouvert 2025 articleOpenAlex

Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers

Giulia Magno, Giulia Rappa, Sophia Stock, Alessandra Holzem et autres

3 citationsBlood Advances

Accès ouvert 2025 articleOpenAlex

448 | BISPECIFIC ANTIBODIES AS HOLDING OR BRIDGING THERAPY BEFORE CAR‐T IN LARGE B‐CELL LYMPHOMA

Hanna Katharina Zieger, META A. NEUMANN, Evgenii Shumilov, Julia Katharina Scholz et autres

6 citationsHematological Oncology

Accès ouvert 2025 articleOpenAlex

327 | LONG‐TERM OUTCOME OF PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA ACHIEVING CR USING BISPECIFIC ANTIBODIES

Evgenii Shumilov, Paolo Mazzeo, Joseph Kauer, Hristo Boyadzhiev et autres

0 citationsHematological Oncology

Accès ouvert 2025 articleOpenAlex

159 | R‐POLA‐GLO – CHEMO‐LIGHT FRONTLINE THERAPY INDUCES HIGH RESPONSE RATES WITH A FAVORABLE SAFETY PROFILE IN ELDERLY/FRAIL PATIENTS WITH AGGRESSIVE LYMPHOMA

Rebecca Wurm‐Kuczera, Thomas Melchardt, P. Pichler, A. Huster et autres

3 citationsHematological Oncology

Accès ouvert 2025 articleOpenAlex

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib, Paolo Mazzeo et autres

36 citationsBlood Advances

Accès ouvert 2024 articleOpenAlex

Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study

Evgenii Shumilov, Rebecca Wurm‐Kuczera, Andrea Kerkhoff, Meng Wang et autres

33 citationsBlood Advances

Accès ouvert 2024 conference-abstractOpenAlex

Outcomes of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Multicenter Real-World Analysis

Philipp Berning, David Baden, Philipp Faustmann, Snjezana Janjetovic et autres

0 citationsBlood

Accès ouvert 2024 conference-abstractOpenAlex

Inflammation-Based Scores Predict Survival after CD3xCD20 Bispecific T Cell Engagers in R/R LBCL

Giulia Magno, Kai Rejeski, Giulia Rappa, Sophia Stock et autres

2 citationsBlood

Accès ouvert 2024 conference-abstractOpenAlex

Exploiting TCF3-Driven Oncogenic Circuits in Burkitt Lymphoma

Jens Löber, Nazli Serin, Salaheddine Ali, Petra Vočková et autres

0 citationsBlood

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.